SPOTLIGHT -
For Staudt, a Keen Eye Sparks Opportunities to Dig Deeper
Driven by his twin passions for music and science, Louis M. Staudt, MD, PhD, has made a career out of reading between the notes.
Read More
Investigators Set Sights on Optimizing CAR T-Cell Therapy in Lymphoma
Five years since the first FDA approval of CAR T-cell therapy in relapsed/refractory lymphoma, there is still much to learn about how to optimize its use, according to Sattva S. Neelapu, MD.
Running, a Lot of Discipline, and a Little Bit of Jazz: Walter J. Curran Jr Is a Giant of Cancer Care in Radiation Oncology
Walter J. Curran Jr, MD, always had the potential to be an overachiever, but his sense of discipline turned that potential into reality.
Immunotherapy Must Become More Precise and Personalized in Lung Cancer
Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL
Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
